Vaidya Sane
Q3 FY25 Earnings Call Analysis
Healthcare Equipment & Supplies
fundraise: Yescapex: Yesrevenue: Category 2margin: Category 1orderbook: Yes
💰fundraise
Any current/future new fundraising through debt or equity?
- The company has issued 40 lakh preferential warrants to institutional investors, pending NSE approval for 25% payment to be received.
- No new equity fundraising announced beyond this; the receipt of funds depends on regulatory approval.
- No mention of fresh debt-raising plans in the current discussion or future outlook.
- Existing capital raise proceeds from warrants are primarily earmarked for hospital expansions (Khopoli and Nagpur).
- The company is focusing on internal cash flow generation to fund growth, indicating limited reliance on external debt.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- **Current/future CAPEX plans:**
- Expansion of hospitals at Khopoli (100 extra beds) and Nagpur (80 beds) with an estimated investment of INR 25-30 crores.
- Vadodara hospital expansion on a rental model; no construction CAPEX expected but installation costs applicable.
- Ongoing construction started for Khopoli hospital expansion; Nagpur hospital CAPEX to commence in 3-4 months.
- Capacity expansion at Nagpur hospital adding 5 beds, investment approx. INR 55 lakhs.
- Launch of Urja Neuro Care facility focused on integrative neuro treatments, estimated cost about INR 1.8 crores.
- Plans to increase bed capacity to around 350-370 beds in next 12-15 months.
- Aim to have about 1000 beds nationwide in 2-3 years.
- **Strategic investments:**
- International expansion via collaboration with Maxura Healthcare in Malaysia to establish an Ayurvedic therapy center.
- Investment in marketing and branding (~INR 7 crores amortized over 5 years).
- Strengthening insurance empanelment to improve hospital occupancy.
Overall, aggressive capacity expansion and strategic partnerships are major investment focuses.
📊revenue
Future growth expectations in sales/revenue/volumes?
- FY '26 expected revenue: INR 115-120 crores.
- FY '27 projected sales: Around INR 180 crores; INR 50-55 crores from hospitals, INR 125-135 crores from clinics, with potential to surpass this figure.
- FY '28 sales target: INR 280 crores planned, with aim to surpass and possibly reach INR 320-350 crores.
- EBITDA margins expected to increase to 30%-35% by FY '28 if INR 280 crore turnover is achieved.
- Revenue growth drivers include increased patient footfall in clinics, expansion of hospital bed capacity from current 110 beds to 350+ beds by FY '28.
- Scale-up of Madhavprash sales from 15,000-20,000 units/month currently to target of 1 lakh units/month in next 24 months.
- Expansion plans include adding 6 more hospitals mostly in Gujarat, Maharashtra, Rajasthan, and potential franchise hospital upgrades.
- Overall growth focus on clinics, hospitals, food/nutritional products, and wellness centers.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- FY '26 revenue expected at INR 115-120 crores, with 20% growth and EBITDA margins around 17-18%.
- EBITDA margin targeted to steadily increase, aiming for ~20% by FY '28.
- PAT margins anticipated to rise to about 10-12% by FY '28.
- By FY '28, revenue potential estimated at INR 280 crores or more, possibly reaching INR 320-350 crores, with roughly 30-35% EBITDA margin.
- EBITDA anticipated to grow 1.5x to 2x by FY '28 compared to current, with EBITDA above 30%.
- EPS growth aligned with revenue and profit increases; EPS was INR 4.56 in H1 FY '26, expected to improve with scaling.
- Confidence in maintaining operational discipline, sustainable growth, and expanding patient base to drive earnings.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
The transcript does not explicitly mention current or expected order book or pending orders details. However, relevant points indicating future business and growth pipeline include:
- Expansion plans for hospitals with an increase from 110 beds to approximately 350-370 beds in the next 12-15 months across Khopoli, Nagpur, Vadodara, and Vizag.
- Targeting 1,000 beds nationwide in 2 to 3 years through organic expansion and franchise hospital upgrades.
- Plans to add 40 to 50 new clinics in the current year and 70 to 80 clinics next year.
- Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals.
- Expecting sales to grow to around INR 115-120 crores for FY '26, INR 180 crores for FY '27, and INR 280 crores+ for FY '28.
- Active franchise clinics showing conversion into hospitals (e.g., Kolhapur 5-bed hospital).
No specific order book or pending order values were disclosed.
